Alebund

Alebund is a China-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of renal diseases and related chronic conditions.

Business Model:

Revenue: $10.4M

Employees: 11-50

Detailed Alebund Information

Geographic Data

Alebund headquarters map

Address: 283 Central Huaihai Road

City: Shanghai

State: shanghai municipality

Zip: 200021

Country: CN

Financial Info

Stage:

series b

Raised Last:

$55M

Raised Total:

$115M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Alebund is a China-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of renal diseases and related chronic conditions.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2019 Series A -
1/2020 Series A 3 - Huagai Capital
Lilly Asia Ventures
Med-Fine Capital
Huagai Capital
Lilly Asia Ventures
Med-Fine Capital
4/2023 Series C $0 3H Health Investment
Guojin Capital
Jiangsu Dingxin Capital Management
Lilly Asia Ventures
Octagon Capital Advisors
Quan Capital
Verition Fund Management
Yangzhou Longchuan Holdings
3H Health Investment
Guojin Capital
Jiangsu Dingxin Capital Management
Lilly Asia Ventures
Octagon Capital Advisors
Quan Capital
Verition Fund Management
Yangzhou Longchuan Holdings
3H Health Investment
Guojin Capital
Jiangsu Dingxin Capital Management
Lilly Asia Ventures
Octagon Capital Advisors
Quan Capital
Verition Fund Management
Yangzhou Longchuan Holdings
3H Health Investment
Guojin Capital
Jiangsu Dingxin Capital Management
Lilly Asia Ventures
Octagon Capital Advisors
Quan Capital
Verition Fund Management
Yangzhou Longchuan Holdings
5/2021 Series B $0 3E Bioventures
Lilly Asia Ventures
Med-Fine Capital
Quan Capital
Sherpa Venture Capital
3E Bioventures
Lilly Asia Ventures
Med-Fine Capital
Quan Capital
Sherpa Venture Capital
9/2021 Series B $0 3E Bioventures
3H Health Investment
BioVenture
HT Capital
Lilly Asia Ventures
Loyal Valley Capital
Morningside Ventures
Octagon Capital Advisors
Quan Capital
Sherpa Venture Capital
Verition Fund Management
3E Bioventures
3H Health Investment
BioVenture
HT Capital
Lilly Asia Ventures
Loyal Valley Capital
Morningside Ventures
Octagon Capital Advisors
Quan Capital
Sherpa Venture Capital
Verition Fund Management
11/2020 Series A 1 - Med-Fine Capital
Med-Fine Capital
9/2021 Series B 11 $54.5M 3H Health Investment
Loyal Valley Capital
Morningside Ventures
Octagon Capital
Verition Fund Management
HT Capital
Lilly Asia Ventures
Quan Capital
3E Bioventures Capital
Sherpa Healthcare Partners
3E Bioventures
3H Health Investment
BioVenture
HT Capital
Lilly Asia Ventures
Loyal Valley Capital
Morningside Ventures
Octagon Capital Advisors
Quan Capital
Sherpa Venture Capital
Verition Fund Management
5/2021 Series B 5 $60M Quan Capital
3E Bioventures Capital
Sherpa Healthcare Partners
Lilly Asia Ventures
Med-Fine Capital
3E Bioventures
Lilly Asia Ventures
Med-Fine Capital
Quan Capital
Sherpa Venture Capital
12/2019 Series A - Huagai Capital
Med-Fine Capital
Lilly Asia Ventures
Huagai Capital
Med-Fine Capital
Lilly Asia Ventures
1/2020 Series A 3 - Huagai Capital
Lilly Asia Ventures
Med-Fine Capital
Huagai Capital
Lilly Asia Ventures
Med-Fine Capital
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research